ATE351T1 - Phenylalkylaminoaethylsalicylamid-derivat, seine herstellung und es enthaltende pharmazeutische zusammensetzungen. - Google Patents

Phenylalkylaminoaethylsalicylamid-derivat, seine herstellung und es enthaltende pharmazeutische zusammensetzungen.

Info

Publication number
ATE351T1
ATE351T1 AT79103473T AT79103473T ATE351T1 AT E351 T1 ATE351 T1 AT E351T1 AT 79103473 T AT79103473 T AT 79103473T AT 79103473 T AT79103473 T AT 79103473T AT E351 T1 ATE351 T1 AT E351T1
Authority
AT
Austria
Prior art keywords
acid addition
optical isomer
phenylalkylaminoaethylsalicylamide
derivative
preparation
Prior art date
Application number
AT79103473T
Other languages
German (de)
English (en)
Inventor
Elijah Herman Gold
Wei Chang
Original Assignee
Schering Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corporation filed Critical Schering Corporation
Application granted granted Critical
Publication of ATE351T1 publication Critical patent/ATE351T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/65—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Epoxy Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT79103473T 1978-09-20 1979-09-17 Phenylalkylaminoaethylsalicylamid-derivat, seine herstellung und es enthaltende pharmazeutische zusammensetzungen. ATE351T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94451678A 1978-09-20 1978-09-20
EP79103473A EP0009702B1 (en) 1978-09-20 1979-09-17 A phenylalkylaminoethylsalicylamide, its preparation and pharmaceutical compositions containing it

Publications (1)

Publication Number Publication Date
ATE351T1 true ATE351T1 (de) 1981-11-15

Family

ID=25481553

Family Applications (1)

Application Number Title Priority Date Filing Date
AT79103473T ATE351T1 (de) 1978-09-20 1979-09-17 Phenylalkylaminoaethylsalicylamid-derivat, seine herstellung und es enthaltende pharmazeutische zusammensetzungen.

Country Status (27)

Country Link
EP (1) EP0009702B1 (sv)
JP (3) JPS5555147A (sv)
KR (2) KR830000904A (sv)
AT (1) ATE351T1 (sv)
AU (1) AU528626B2 (sv)
CA (1) CA1151211A (sv)
CY (1) CY1175A (sv)
DD (1) DD150457A5 (sv)
DE (1) DE2961263D1 (sv)
DK (1) DK387579A (sv)
FI (1) FI792884A (sv)
GR (1) GR73179B (sv)
HK (1) HK13383A (sv)
HU (1) HU185523B (sv)
IE (1) IE49301B1 (sv)
IL (1) IL58258A (sv)
KE (1) KE3283A (sv)
MY (1) MY8500042A (sv)
NO (1) NO149660C (sv)
NZ (1) NZ191589A (sv)
OA (1) OA06339A (sv)
PH (1) PH16794A (sv)
PL (1) PL129114B1 (sv)
PT (1) PT70191A (sv)
SG (1) SG283G (sv)
YU (1) YU227379A (sv)
ZA (1) ZA794872B (sv)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4658060A (en) * 1982-04-26 1987-04-14 Schering Corporation Preparation of (-)-5-(beta)-1-hydroxy-2-((beta)-1-methyl-3-phenylpropyl)aminoethyl) salicylamide
IT1194406B (it) * 1983-09-27 1988-09-22 Scharper S P A Procedimento per la preparazione di 2-idrossi-5-01-idrossi-2-((4-fenil-2-butil)ammino) etil benzammide
HU190867B (en) * 1984-01-20 1986-11-28 Egyt Gyogyszervegyeszeti Gyar,Hu Process for preparing 2-hydroxy-5-/1-hydroxy-2-/1-methyl-3-phenyl-propyl/-amino/ethyl/-benzamide and pharmaceutically acceptable salts thereof
US4788183A (en) * 1987-11-30 1988-11-29 Schering Corporation Method for treatment of dyslipidemia in humans
US4879233A (en) * 1989-02-10 1989-11-07 Schering Corporation Novel Aspergillus niveus microorganism used for the chiral reduction of carbonyl groups
US6313146B1 (en) 1991-08-23 2001-11-06 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5858684A (en) * 1991-08-23 1999-01-12 The Brigham And Women's Hospital, Inc. Method of screening calcium receptor-active molecules
US5763569A (en) * 1991-08-23 1998-06-09 The Brigham And Women's Hospital, Inc Calcium receptor-active molecules
US6011068A (en) * 1991-08-23 2000-01-04 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5688938A (en) * 1991-08-23 1997-11-18 The Brigham & Women's Hospital, Inc. Calcium receptor-active molecules
US6031003A (en) * 1991-08-23 2000-02-29 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
MX9204881A (es) * 1991-08-23 1993-04-01 Nps Pharma Inc Composicion farmaceutica que comprende moleculas activas, receptoras de calcio.
US6001884A (en) * 1991-08-23 1999-12-14 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5962314A (en) * 1993-02-23 1999-10-05 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
PT1203761E (pt) 1994-10-21 2005-04-29 Nps Pharma Inc Compostos activos do receptor de calcio
AU731146C (en) 1996-05-01 2005-02-03 Nps Pharmaceuticals, Inc. Inorganic ion receptor-active compounds
IT1313583B1 (it) * 1999-07-30 2002-09-09 Chiesi Farma Spa Derivati 2-amminotetralinici per la terapia del glaucoma.
EP1961735B1 (en) * 2007-02-22 2009-11-18 Indena S.P.A. Process for the preparation of (2r,3s)-3-phenylisoserine methyl ester acetate salt
JP6245983B2 (ja) 2010-08-11 2017-12-13 ドレクセル ユニバーシティ パーキンソン病におけるジスキネジアを治療するための新規ｄ３ドーパミン受容体アゴニスト

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4012444A (en) * 1969-07-08 1977-03-15 Allen & Hanburys Limited 5-[1-Hydroxy-2-(1-methyl-3-phenylpropyl)aminoethyl] salicylamide and physiologically acceptable acid addition salts thereof
GB1266058A (sv) * 1969-07-08 1972-03-08
NL7603965A (nl) * 1975-04-17 1976-10-19 Scherico Ltd Diastereoisomeren van fenylaminoethanolderi- vaten met farmacologische activiteit en werk- wijzen om deze te bereiden.

Also Published As

Publication number Publication date
EP0009702B1 (en) 1981-11-04
CY1175A (en) 1983-06-10
YU227379A (en) 1983-06-30
MY8500042A (en) 1985-12-31
NO149660C (no) 1984-05-30
CA1151211A (en) 1983-08-02
IL58258A0 (en) 1979-12-30
ZA794872B (en) 1980-11-26
JPH0210128B2 (sv) 1990-03-06
KR830000904A (ko) 1983-04-28
IL58258A (en) 1984-01-31
EP0009702A1 (en) 1980-04-16
NZ191589A (en) 1984-03-30
HK13383A (en) 1983-04-29
IE791770L (en) 1980-03-20
OA06339A (fr) 1981-06-30
JPS59108749A (ja) 1984-06-23
FI792884A (fi) 1980-03-21
SG283G (en) 1983-09-16
DE2961263D1 (en) 1982-01-14
AU528626B2 (en) 1983-05-05
PL129114B1 (en) 1984-03-31
PT70191A (en) 1979-10-01
PL218408A1 (sv) 1980-09-08
JPH02167253A (ja) 1990-06-27
DK387579A (da) 1980-03-21
KR890001998B1 (ko) 1989-06-07
GR73179B (sv) 1984-02-14
PH16794A (en) 1984-02-28
KE3283A (en) 1983-05-13
DD150457A5 (de) 1981-09-02
NO792993L (no) 1980-03-21
NO149660B (no) 1984-02-20
HU185523B (en) 1985-02-28
KR840005307A (ko) 1984-11-05
AU5088179A (en) 1980-03-27
JPS5555147A (en) 1980-04-22
IE49301B1 (en) 1985-09-18

Similar Documents

Publication Publication Date Title
ATE351T1 (de) Phenylalkylaminoaethylsalicylamid-derivat, seine herstellung und es enthaltende pharmazeutische zusammensetzungen.
DE69033915D1 (de) Xanthinderivate, Verfahren zu ihrer Herstellung und ihre pharmazeutische Anwendung
PT92935A (pt) Processo para a preparacao de um composto de pirazolo-piridina e de composicoes farmaceuticas que o contem
ES2081187T3 (es) Nuevas naftil-alquil-aminas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
AU8794291A (en) New oxazolopyridine derivatives, processes for preparing these and pharmaceutical compositions containing them
ES2179996T3 (es) Cefalosporinas de vinil-pirrolidinona con sustituyentes basicos.
KR890011902A (ko) 디데옥시디데히드로카르보시클릭 뉴클레오시드
NO902800D0 (no) Fremgangsmaate for fremstilling av 11beta-aryl-4-oestrener.
DE69215965D1 (de) Pyrazolopyridinverbindungen und Verfahren zu ihrer Herstellung
AU624031B2 (en) Compositions and their use in lowering intraocular pressure
FI911131A (sv) Förfarande för framställning av 3-arylkarbonyl-1-aminoalkyl-1H-indolföreningar med antiglaukomaeffekt
BR9611276A (pt) Composto formulação farmacêutica processo para tratamento ou profilaxia de doenças ou condições de seres humanos e uso de um composto
ATE204278T1 (de) Serotoninergische ergolin derivate
WO1990003172A3 (en) Bile acids for treatment of viral infections
BR8304268A (pt) Composicoes fungicidas e processos para o combate de fungos, para a protecao de plantas e para a preparacao de composicoes
DK105183D0 (da) Fremgangsmade til fremstilling af 1,4-diaminocyclitolderivater
GB2316406A (en) Free radical scavenger molecules
AU659738B2 (en) New pyrrolothienopyrazine compounds, processes for the preparation thereof, and pharmaceutical compositions containing them
ES8403135A1 (es) Un procedimiento para la preparacion de acido 6,-metoxi-6, -2-2-metilfenoxicarbonil-2-(tien-3-il) acetamido penicilanico.
KR890003678A (ko) 부정맥 치료제
RU99125836A (ru) Фармацевтические композиции, содержащие производные гидроксамовой кислоты

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee